🚀 VC round data is live in beta, check it out!
Joint Valuation Multiples
Discover revenue and EBITDA valuation multiples for Joint and similar public comparables like Eureka Group Holdings, Radius Residential, DocGo, Biote and more.
Joint Overview
About Joint
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has one operating business segment; The Franchise Operations segment which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the Company’s franchise license, which represents symbolic intellectual property.
Founded
2010
HQ
Employees
736
Website
Sectors
Financials (LTM)
EV
$105M
Joint Financials
Joint reported last 12-month revenue of $56M and EBITDA of $13M.
In the same LTM period, Joint generated $45M in gross profit, $13M in EBITDA, and $1M in net income.
Revenue (LTM)
Joint P&L
In the most recent fiscal year, Joint reported revenue of $55M and EBITDA of $13M.
Joint expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $56M | XXX | $55M | XXX | XXX | XXX |
| Gross Profit | $45M | XXX | $44M | XXX | XXX | XXX |
| Gross Margin | 80% | XXX | 80% | XXX | XXX | XXX |
| EBITDA | $13M | XXX | $13M | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | 24% | XXX | XXX | XXX |
| EBIT Margin | 1% | XXX | (2%) | XXX | XXX | XXX |
| Net Profit | $1M | XXX | $3M | XXX | XXX | XXX |
| Net Margin | 2% | XXX | 5% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Joint Stock Performance
Joint has current market cap of $126M, and enterprise value of $105M.
Market Cap Evolution
Joint's stock price is $8.82.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $105M | $126M | -1.2% | XXX | XXX | XXX | $0.20 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialJoint Valuation Multiples
Joint trades at 1.9x EV/Revenue multiple, and 8.1x EV/EBITDA.
EV / Revenue (LTM)
Joint Financial Valuation Multiples
As of April 11, 2026, Joint has market cap of $126M and EV of $105M.
Equity research analysts estimate Joint's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Joint has a P/E ratio of 102.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $126M | XXX | $126M | XXX | XXX | XXX |
| EV (current) | $105M | XXX | $105M | XXX | XXX | XXX |
| EV/Revenue | 1.9x | XXX | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | 8.1x | XXX | 8.1x | XXX | XXX | XXX |
| EV/EBIT | 248.9x | XXX | (115.7x) | XXX | XXX | XXX |
| EV/Gross Profit | 2.3x | XXX | 2.4x | XXX | XXX | XXX |
| P/E | 102.2x | XXX | 43.5x | XXX | XXX | XXX |
| EV/FCF | 24.7x | XXX | 20.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Joint Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Joint Margins & Growth Rates
Joint's revenue in the last 12 month grew by 6%.
Joint's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Joint's rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Joint's rule of X is 46% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Joint Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 10% | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | 24% | XXX | XXX | XXX |
| EBITDA Growth | (0%) | XXX | (1%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 31% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 46% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 24% | XXX | 24% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 52% | XXX | 54% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 81% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Joint Public Comps
See public comps and valuation multiples for other Long-Term Care comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Eureka Group Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Radius Residential | XXX | XXX | XXX | XXX | XXX | XXX |
| DocGo | XXX | XXX | XXX | XXX | XXX | XXX |
| Biote | XXX | XXX | XXX | XXX | XXX | XXX |
| Maternus-Kliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Joint M&A Activity
Joint acquired XXX companies to date.
Last acquisition by Joint was on XXXXXXXX, XXXXX. Joint acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Joint
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialJoint Investment Activity
Joint invested in XXX companies to date.
Joint made its latest investment on XXXXXXXX, XXXXX. Joint invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Joint
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Joint
| When was Joint founded? | Joint was founded in 2010. |
| Where is Joint headquartered? | Joint is headquartered in United States. |
| How many employees does Joint have? | As of today, Joint has over 736 employees. |
| Who is the CEO of Joint? | Joint's CEO is Sanjiv Kumar Razdan. |
| Is Joint publicly listed? | Yes, Joint is a public company listed on Nasdaq. |
| What is the stock symbol of Joint? | Joint trades under JYNT ticker. |
| When did Joint go public? | Joint went public in 2014. |
| Who are competitors of Joint? | Joint main competitors are Eureka Group Holdings, Radius Residential, DocGo, Biote. |
| What is the current market cap of Joint? | Joint's current market cap is $126M. |
| What is the current revenue of Joint? | Joint's last 12 months revenue is $56M. |
| What is the current revenue growth of Joint? | Joint revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Joint? | Current revenue multiple of Joint is 1.9x. |
| Is Joint profitable? | Yes, Joint is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Joint? | Joint's last 12 months EBITDA is $13M. |
| What is Joint's EBITDA margin? | Joint's last 12 months EBITDA margin is 23%. |
| What is the current EV/EBITDA multiple of Joint? | Current EBITDA multiple of Joint is 8.1x. |
| What is the current FCF of Joint? | Joint's last 12 months FCF is $4M. |
| What is Joint's FCF margin? | Joint's last 12 months FCF margin is 8%. |
| What is the current EV/FCF multiple of Joint? | Current FCF multiple of Joint is 24.7x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.